Insys Therapeutics, Inc. to Present at 2017 RBC Ca
Post# of 301275
PHOENIX, Feb. 14, 2017 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (“Insys” or “the Company”) (NASDAQ: INSY ) today announced that Santosh Vetticaden, MD, PhD, Interim Chief Executive Officer, and Chief Medical Officer, and Darryl Baker, Chief Financial Officer, will present at the 2017 RBC Capital Markets Global Healthcare Conference as follows:
| Date: | Thursday, February 23, 2017 | |
| Time: | 1:35 p.m. Eastern Standard Time | |
| Location: | The New York Palace | |
The presentation will be webcast live at the aforementioned time as well as archived for 90 days thereafter, via the Company’s website at www.insysrx.com , under the Investors Section or at http://www.veracast.com/webcasts/rbc/healthca...290235.cfm .
About Insys Therapeutics, Inc. Insys Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve the quality of life of patients.
Investor Contact: Lisa M. Wilson Email: lwilson@insitecony.com
(0)
(0)